Glycosylphosphatidylinositols
"Glycosylphosphatidylinositols" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds containing carbohydrate or glycosyl groups linked to phosphatidylinositols. They anchor GPI-LINKED PROTEINS or polysaccharides to cell membranes.
| Descriptor ID |
D017261
|
| MeSH Number(s) |
D09.400.410.475 D10.390.475 D10.570.755.375.760.400.942.250
|
| Concept/Terms |
Glycosylphosphatidylinositols- Glycosylphosphatidylinositols
- Glycosyl-Phosphatidylinositol
- Glycosyl Phosphatidylinositol
- Glycosylphosphatidylinositol
- Gly-PtdIns
- Glycosylated Phosphatidylinositols
- Phosphatidylinositols, Glycosylated
Glycosylphosphatidylinositol Anchors- Glycosylphosphatidylinositol Anchors
- Anchors, Glycosylphosphatidylinositol
- Glycosyl-Phosphatidylinositol Membrane Protein Anchors
- Glycosyl Phosphatidylinositol Membrane Protein Anchors
- GPI Membrane Anchors
- Anchors, GPI Membrane
- Membrane Anchors, GPI
- Glycoinositol Phospholipid Membrane Anchor
|
Below are MeSH descriptors whose meaning is more general than "Glycosylphosphatidylinositols".
Below are MeSH descriptors whose meaning is more specific than "Glycosylphosphatidylinositols".
This graph shows the total number of publications written about "Glycosylphosphatidylinositols" by people in this website by year, and whether "Glycosylphosphatidylinositols" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1998 | 1 | 1 | 2 |
| 2000 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glycosylphosphatidylinositols" by people in Profiles.
-
The clinical and genetic spectrum of inherited glycosylphosphatidylinositol deficiency disorders. Brain. 2024 Aug 01; 147(8):2775-2790.
-
Presentation clinical, haematological and immunophenotypic features of 1081 patients with GPI-deficient (paroxysmal nocturnal haemoglobinuria) cells detected by flow cytometry. Br J Haematol. 2020 06; 189(5):954-966.
-
Homozygous splice-variants in human ARV1 cause GPI-anchor synthesis deficiency. Mol Genet Metab. 2020 05; 130(1):49-57.
-
A population of CD20+CD27+CD43+CD38lo/int B1 cells in PNH are missing GPI-anchored proteins and harbor PIGA mutations. Blood. 2019 07 04; 134(1):89-92.
-
Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice. J Virol. 2017 Feb 01; 91(3).
-
Glycosyl Phosphatidylinositol-Anchored C34 Peptide Derived From Human Immunodeficiency Virus Type 1 Gp41 Is a Potent Entry Inhibitor. J Neuroimmune Pharmacol. 2016 09; 11(3):601-10.
-
Cell surface engineering using glycosylphosphatidylinositol anchored tissue inhibitor of matrix metalloproteinase-1 stimulates cutaneous wound healing. Wound Repair Regen. 2014 Jan-Feb; 22(1):70-6.
-
Trimeric glycosylphosphatidylinositol-anchored HCDR3 of broadly neutralizing antibody PG16 is a potent HIV-1 entry inhibitor. J Virol. 2013 Feb; 87(3):1899-905.
-
Potent and broad anti-HIV-1 activity exhibited by a glycosyl-phosphatidylinositol-anchored peptide derived from the CDR H3 of broadly neutralizing antibody PG16. J Virol. 2011 Sep; 85(17):8467-76.
-
GPI-anchored single chain Fv--an effective way to capture transiently-exposed neutralization epitopes on HIV-1 envelope spike. Retrovirology. 2010 Oct 06; 7:79.